Jane Street Group LLC Makes New Investment in U.S. Physical Therapy, Inc. (NYSE:USPH)

Jane Street Group LLC bought a new position in U.S. Physical Therapy, Inc. (NYSE:USPH) during…

Jane Street Group LLC bought a new position in U.S. Physical Therapy, Inc. (NYSE:USPH) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 2,507 shares of the company’s stock, valued at approximately $203,000.

A number of other institutional investors also recently added to or reduced their stakes in USPH. Albert D Mason Inc. lifted its holdings in shares of U.S. Physical Therapy by 3.5% during the second quarter. Albert D Mason Inc. now owns 6,951 shares of the company’s stock valued at $563,000 after purchasing an additional 236 shares in the last quarter. Advisor Group Holdings Inc. lifted its holdings in shares of U.S. Physical Therapy by 5.0% during the second quarter. Advisor Group Holdings Inc. now owns 5,004 shares of the company’s stock valued at $404,000 after purchasing an additional 237 shares in the last quarter. Bank of America Corp DE increased its position in U.S. Physical Therapy by 0.5% during the second quarter. Bank of America Corp DE now owns 60,600 shares of the company’s stock valued at $4,910,000 after acquiring an additional 290 shares during the last quarter. California Public Employees Retirement System increased its position in U.S. Physical Therapy by 1.1% during the second quarter. California Public Employees Retirement System now owns 28,945 shares of the company’s stock valued at $2,345,000 after acquiring an additional 309 shares during the last quarter. Finally, American International Group Inc. increased its position in U.S. Physical Therapy by 3.7% during the second quarter. American International Group Inc. now owns 8,984 shares of the company’s stock valued at $728,000 after acquiring an additional 321 shares during the last quarter.

A number of research firms recently commented on USPH. Barrington Research upped their price objective on U.S. Physical Therapy from $95.00 to $100.00 and gave the company an “outperform” rating in a research report on Friday, August 7th. ValuEngine cut U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research report on Tuesday, September 1st. Finally, Zacks Investment Research upgraded U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $100.00 price objective for the company in a research report on Saturday, August 8th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $93.33.

Shares of USPH opened at $85.70 on Wednesday. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.13. The business has a 50-day simple moving average of $89.35 and a two-hundred day simple moving average of $78.28. The stock has a market cap of $1.10 billion, a price-to-earnings ratio of 35.71, a PEG ratio of 4.17 and a beta of 1.22. U.S. Physical Therapy, Inc. has a 52 week low of $45.13 and a 52 week high of $148.48.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of ($0.18) by $1.03. The business had revenue of $83.86 million during the quarter, compared to analysts’ expectations of $87.24 million. U.S. Physical Therapy had a return on equity of 13.36% and a net margin of 6.64%. The business’s quarterly revenue was down 33.6% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.81 earnings per share. On average, equities analysts anticipate that U.S. Physical Therapy, Inc. will post 1.82 earnings per share for the current fiscal year.

In other news, CFO Lawrance W. Mcafee sold 4,450 shares of the company’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $91.41, for a total value of $406,774.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Graham D. Reeve sold 1,500 shares of the company’s stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $90.21, for a total value of $135,315.00. The disclosure for this sale can be found here. Corporate insiders own 2.00% of the company’s stock.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Story: How Do Mutual Funds Work?

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for U.S. Physical Therapy and related companies with MarketBeat.com’s FREE daily email newsletter.